Q32 Bio Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$6.19

-0.06 (-0.96%)

As of May 16, 2:19 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 78%

Hold 2 22%

Sell 0 0%

Price Target

Analyst Price Target +351.4% upside

Low Target $24.18

Average Target $27.94

High Target $39.76

Current Price $6.19

Current
$6.19

Target
$27.94

$24.18 $27.94 avg $39.76

Scenario Analysis

Bear Case

$24.18

290.6%

Low target

Base Case

$27.94

+351.4%

Avg target

Bull Case

$39.76

+542.3%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$8.05

-23.1% from high

52-Week Low

$1.35

+360.2% from low

Target vs 52W High

$27.94

+247.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%